MedPath

MUHAMMAD FURQAN

🇵🇰Pakistan
Ownership
-
Employees
-
Market Cap
-
Website

Ascorbate with Durvalumab in Non-Small Cell Lung Cancer (NSCLC)

Phase 1
Recruiting
Conditions
Non-small Cell Lung Cancer
Interventions
First Posted Date
2023-10-16
Last Posted Date
2024-11-04
Lead Sponsor
Muhammad Furqan
Target Recruit Count
36
Registration Number
NCT06083454
Locations
🇺🇸

University of Iowa, Iowa City, Iowa, United States

Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer

Phase 2
Recruiting
Conditions
Extensive Stage Small Cell Lung Cancer
Interventions
First Posted Date
2021-01-07
Last Posted Date
2024-10-26
Lead Sponsor
Muhammad Furqan
Target Recruit Count
30
Registration Number
NCT04699838
Locations
🇺🇸

University of Illinois Medical Center, Chicago, Illinois, United States

🇺🇸

University of Maryland, Baltimore, Maryland, United States

🇺🇸

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

and more 2 locations

PDR001 + Panobinostat for Melanoma and NSCLC

Phase 1
Withdrawn
Conditions
Melanoma
Non Small Cell Lung Cancer
Interventions
First Posted Date
2019-06-11
Last Posted Date
2019-10-04
Lead Sponsor
Muhammad Furqan
Registration Number
NCT03982134

Use Peripheral Blood Proteomics to Predict the Treatment Response and Toxicities in NSCLC Immunotherapy

Terminated
Conditions
Non Small Cell Lung Cancer
First Posted Date
2019-05-15
Last Posted Date
2023-10-12
Lead Sponsor
Muhammad Furqan
Target Recruit Count
29
Registration Number
NCT03951012
Locations
🇺🇸

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer

Phase 2
Active, not recruiting
Conditions
Small Cell Lung Cancer (SCLC)
Interventions
First Posted Date
2016-05-12
Last Posted Date
2024-08-01
Lead Sponsor
Muhammad Furqan
Target Recruit Count
32
Registration Number
NCT02769832
Locations
🇺🇸

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

© Copyright 2025. All Rights Reserved by MedPath